Abstract
The treatment of rheumatoid arthritis (RA), a chronic, systemic, autoimmune disease, has been greatly advanced by the introduction of biologic disease-modifying antirheumatic drugs (DMARDs); howeve...
Funding Information
  • Astellas Pharma Inc. Astellas Pharma (N/A)

This publication has 55 references indexed in Scilit: